<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all Joachim Scholz stories</title>
 <link>http://harvardscience.harvard.edu/stories/person/20328</link>
 <description>Stories and external links referencing a person (RSS)</description>
 <language>en</language>
<item>
 <title>Simple bedside test improves diagnosis of chronic back pain</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/simple-bedside-test-improves-diagnosis-chronic-back-pain</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A simple and inexpensive method of assessing pain, developed by Harvard researchers at &lt;a title=&quot;Massachusetts General Hospital&quot; href=&quot;http://www.harvardscience.harvard.edu/directory/programs/massachusetts-general-hospital&quot;&gt;Massachusetts General Hospital&lt;/a&gt; (MGH), is better than currently used techniques for distinguishing neuropathic pain – pain caused by damage to the nervous system — from other types of chronic back pain.&amp;nbsp; Being able to more precisely determine the underlying nature of the pain is essential to choosing the best treatment.&amp;nbsp; The &lt;a title=&quot;report&quot; href=&quot;http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000047&quot;&gt;report&lt;/a&gt; appears in tomorrow&#039;s edition of the open-access journal PLoS Medicine. &lt;br /&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/simple-bedside-test-improves-diagnosis-chronic-back-pain&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 06 Apr 2009 15:07:59 -0400</pubDate>
 <dc:creator>50443248</dc:creator>
 <guid isPermaLink="false">20702 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement</title>
 <link>http://harvardscience.harvard.edu/foundations/articles/glaxosmithkline-and-harvard-stem-cell-institute-announce-major-collaboration-ag</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;&lt;a title=&quot;&quot; href=&quot;http://www.gsk.com/research/index.html&quot;&gt;GlaxoSmithKline&lt;/a&gt; (GSK) and the &lt;a title=&quot;&quot; href=&quot;http://www.hsci.harvard.edu&quot;&gt;Harvard Stem Cell Institute&lt;/a&gt; (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/foundations/articles/glaxosmithkline-and-harvard-stem-cell-institute-announce-major-collaboration-ag&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 21 Jul 2008 15:00:05 -0400</pubDate>
 <dc:creator>404132862</dc:creator>
 <guid isPermaLink="false">20327 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
